Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2008 1
2009 1
2011 1
2012 2
2013 1
2014 2
2015 1
2016 3
2017 2
2018 2
2019 5
2020 14
2021 14
2022 9
2023 11
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: lopez manzanares l. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Among authors: lopez manzanares l. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.
[Bases of deep brain stimulation].
Torres CV, López-Manzanares L, Pulido-Rivas P, Iza-Vallejo B, Pérez S, Navas-García M. Torres CV, et al. Among authors: lopez manzanares l. Rev Neurol. 2020 Apr 16;70(8):293-299. doi: 10.33588/rn.7008.2019396. Rev Neurol. 2020. PMID: 32242336 Free article. Review. Spanish.
Cognitive impairment and dementia in young onset Parkinson's disease.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, García Díaz I, Íñiguez Alvarado MC, Paz JM, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Seijo M, Valero C, Alonso Redondo R, Buongiorno MT, Ordás C, Menéndez-González M, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: lopez manzanares l. J Neurol. 2023 Dec;270(12):5793-5812. doi: 10.1007/s00415-023-11921-w. Epub 2023 Aug 14. J Neurol. 2023. PMID: 37578489
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, García Díaz I, Alvarado MCÍ, Paz JM, Jesús S, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Seijo M, Valero C, Alonso Redondo R, Buongiorno MT, Ordás C, Menéndez-González M, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: lopez manzanares l. Brain Behav. 2023 Dec;13(12):e3295. doi: 10.1002/brb3.3295. Epub 2023 Nov 8. Brain Behav. 2023. PMID: 37939322 Free PMC article.
Bupropion-induced parkinsonism.
Grandas F, López-Manzanares L. Grandas F, et al. Among authors: lopez manzanares l. Mov Disord. 2007 Sep 15;22(12):1830-1. doi: 10.1002/mds.21425. Mov Disord. 2007. PMID: 17534961 No abstract available.
[Deep brain stimulation in drug-resistant epilepsy].
Torres CV, Iza-Vallejo B, Navas-García M, Pulido-Rivas P, López-Manzanares L, Pérez S. Torres CV, et al. Among authors: lopez manzanares l. Rev Neurol. 2020 Mar 1;70(5):183-192. doi: 10.33588/rn.7005.2019395. Rev Neurol. 2020. PMID: 32100279 Free article. Review. Spanish.
Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study.
Stocchi F, Rascol O, Poewe W, Chaudhuri KR, Kassubek J, Lopez Manzanares L, Zhang Y, Bowling A, Pappert E, Wu S; CTH-302 Study Investigators. Stocchi F, et al. Among authors: lopez manzanares l. J Parkinsons Dis. 2023;13(8):1329-1342. doi: 10.3233/JPD-230072. J Parkinsons Dis. 2023. PMID: 37980683 Free PMC article. Clinical Trial.
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Westenberger A, Skrahina V, Usnich T, Beetz C, Vollstedt EJ, Laabs BH, Paul JJ, Curado F, Skobalj S, Gaber H, Olmedillas M, Bogdanovic X, Ameziane N, Schell N, Aasly JO, Afshari M, Agarwal P, Aldred J, Alonso-Frech F, Anderson R, Araújo R, Arkadir D, Avenali M, Balal M, Benizri S, Bette S, Bhatia P, Bonello M, Braga-Neto P, Brauneis S, Cardoso FEC, Cavallieri F, Classen J, Cohen L, Coletta D, Crosiers D, Cullufi P, Dashtipour K, Demirkiran M, de Carvalho Aguiar P, De Rosa A, Djaldetti R, Dogu O, Dos Santos Ghilardi MG, Eggers C, Elibol B, Ellenbogen A, Ertan S, Fabiani G, Falkenburger BH, Farrow S, Fay-Karmon T, Ferencz GJ, Fonoff ET, Fragoso YD, Genç G, Gorospe A, Grandas F, Gruber D, Gudesblatt M, Gurevich T, Hagenah J, Hanagasi HA, Hassin-Baer S, Hauser RA, Hernández-Vara J, Herting B, Hinson VK, Hogg E, Hu MT, Hummelgen E, Hussey K, Infante J, Isaacson SH, Jauma S, Koleva-Alazeh N, Kuhlenbäumer G, Kühn A, Litvan I, López-Manzanares L, Luxmore M, Manandhar S, Marcaud V, Markopoulou K, Marras C, McKenzie M, Matarazzo M, Merello M, Mollenhauer B, Morgan JC, Mullin S, Musacchio T, Myers B, Negrotti A, Nieves A, Nitsan Z, Oskooilar N, Öztop-Çakmak Ö, Pal G, Pavese N, Percese… See abstract for full author list ➔ Westenberger A, et al. Among authors: lopez manzanares l. Brain. 2024 Aug 1;147(8):2652-2667. doi: 10.1093/brain/awae188. Brain. 2024. PMID: 39087914 Free PMC article.
Hemihypomimia in Parkinson's disease: an under-recognized clinical sign?
Guerra-Hiraldo JD, López-Jiménez A, Gasca-Salas C, Maycas-Cepeda T, Gómez-Sanchez P, López-Manzanares L, Mata Guerra-Hiraldo M, Prieto-Jurczynska C, Eimil M, Vela-Desojo L, Pareés I, Jiménez-Huete A, Kurtis MM. Guerra-Hiraldo JD, et al. Among authors: lopez manzanares l. J Neurol. 2023 Jan;270(1):548-551. doi: 10.1007/s00415-022-11292-8. Epub 2022 Aug 4. J Neurol. 2023. PMID: 35925399 No abstract available.
70 results